Guangwu Zhu

<i>BRAF</i> V600E and <i>TERT</i> Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

Mingzhao Xing, Rengyun Liu, Xiaoli Liu et al. · Journal of Clinical Oncology · 2014 · 715 citations · Full text

Medicine, Genetics, Oncology +15

<i>TERT</i>Promoter Mutations and Their Association with<i>BRAF</i>V600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer

Xiaoli Liu, Shen Qu, Rengyun Liu et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 316 citations · Full text

Medicine, Genetics, Oncology +15

Mortality Risk Stratification by Combining <i>BRAF </i>V600E and <i>TERT</i> Promoter Mutations in Papillary Thyroid Cancer

Rengyun Liu, Justin A. Bishop, Guangwu Zhu et al. · JAMA Oncology · 2016 · 289 citations

Medicine, Genetics, Oncology +14

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer

Rengyun Liu, Tao Zhang, Guangwu Zhu et al. · Nature Communications · 2018 · 182 citations · Full text

Medicine, Molecular Biology, Oncology +17

High Prevalence and Mutual Exclusivity of Genetic Alterations in the Phosphatidylinositol-3-Kinase/Akt Pathway in Thyroid Tumors

Yangang Wang, Peng Hou, Hongyu Yu et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 174 citations

Medicine, Genetics, Molecular Genetics +17